$34.90
0.290.84%
Last update: Sep 1, 8:50 AM
Pharvaris (PHVS) institutional and insider ownership, recent insider transactions and ownership breakdown.
Shares Outstanding
69.880M
Shares Float
57.504M
Insider Shares Owned
339.051K
Insider % Owned
0.5%
Institutional Shares Held
11.804M
Institutional % Held
16.8%
Ownership Breakdown
Net Insider Activity by Month
Purchases (90d)
0
Sales (90d)
8
$4.3M total
Net Activity
Net Selling
Net Value (90d)
-$4.3M
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Berndt Modig | CHIEF EXECUTIVE OFFICER | SELL | 2.292K | $34.77 | $80K |
| Jul 13, 2026 | Berndt Modig | CHIEF EXECUTIVE OFFICER | SELL | 2.292K | $34.97 | $80K |
| Jun 29, 2026 | Johannes Schikan | — | SELL | 37.600K | $35.41 | $1.3M |
| Jun 29, 2026 | Anne Lesage | CHIEF EARLY DEVELOPMENT | SELL | 37.700K | $21.12 | $2.4M |
| Jun 29, 2026 | Johannes Schikan | — | SELL | 2.400K | $35.10 | $84K |
| Jun 25, 2026 | Anne Lesage | CHIEF EARLY DEVELOPMENT | SELL | 2.300K | $19.92 | $151K |
| Jun 25, 2026 | Peng Lu | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $18.45 | $942K |
| Jun 18, 2026 | Peng Lu | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $18.30 | $9K |
| Jun 15, 2026 | Berndt Modig | CHIEF EXECUTIVE OFFICER | SELL | 2.291K | $31.07 | $71K |
| Jun 4, 2026 | Anna Nijdam | PRINCIPAL ACCOUNTING OFFICER | SELL | 2.670K | $30.87 | $82K |
| May 21, 2026 | Viviane Monges | — | SELL | 9.667K | $30.29 | $293K |
| May 21, 2026 | Anna Nijdam | PRINCIPAL ACCOUNTING OFFICER | SELL-OPTIONS | — | $25.35 | $78K |
| May 21, 2026 | David W Nassif | CFO / CLO | SELL | 10.000K | $30.31 | $303K |
| May 20, 2026 | Elisabeth Bjork | — | SELL-OPTIONS | — | $18.68 | $213K |
| May 18, 2026 | Berndt Modig | CHIEF EXECUTIVE OFFICER | SELL | 2.292K | $29.22 | $67K |
| May 15, 2026 | Robert Glassman | — | SELL | 4.667K | $26.07 | $179K |
| May 15, 2026 | Stefan Abele | CHIEF TECHNICAL OPS OFFICER | SELL | 8.748K | $29.82 | $261K |
| May 15, 2026 | Wim Souverijins | CHIEF COMMERCIAL OFFICER | SELL | 10.000K | $29.92 | $299K |
| May 1, 2026 | Peng Lu | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $16.38 | $391K |
| Apr 29, 2026 | Johannes Schikan | — | SELL | 32.900K | $30.29 | $997K |
| Apr 29, 2026 | Anne Lesage | CHIEF EARLY DEVELOPMENT | SELL | 22.900K | $18.34 | $1.3M |
| Apr 29, 2026 | Peng Lu | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $16.40 | $517K |
| Apr 22, 2026 | Johannes Schikan | — | SELL | 7.100K | $30.05 | $213K |
| Apr 22, 2026 | Anne Lesage | CHIEF EARLY DEVELOPMENT | SELL | 7.100K | $18.83 | $384K |
| Apr 22, 2026 | Peng Lu | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $16.32 | $195K |
| Apr 16, 2026 | Berndt Modig | CHIEF EXECUTIVE OFFICER | SELL | 2.292K | $28.60 | $66K |
| Apr 9, 2026 | Berndt Modig | CHIEF EXECUTIVE OFFICER | SELL | 23.333K | $27.74 | $647K |
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
